نتائج البحث - "Friedrich Overkamp"

1

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

المصدر: European Journal of Cancer. 155:1-12

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9454fc61f6be3b80d26db44b681593Test
https://doi.org/10.1016/j.ejca.2021.06.033Test

2

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

المصدر: The Breast. 37:42-51

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Receptor, ErbB-2, medicine.drug_class, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Germany, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Everolimus, Registries, Neoplasm Metastasis, skin and connective tissue diseases, Fulvestrant, Aged, 030219 obstetrics & reproductive medicine, Aromatase inhibitor, Estradiol, Aromatase Inhibitors, business.industry, Cancer, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Tamoxifen, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Surgery, Neoplasm Grading, Receptors, Progesterone, business, medicine.drug, Antihormone therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e357d459577e9ac0652f090e1913d7Test
https://doi.org/10.1016/j.breast.2017.10.002Test

3

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

المصدر: The Breast. 37:154-160

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99f196fde9a1054ca985dd06e625f05Test
https://doi.org/10.1016/j.breast.2017.08.008Test

4

Impact of prophylactic systemic antibiotics (SA) on outcome of patients (pts) with RAS-wildtype (RAS-wt) metastatic colorectal carcinoma (mCRC) treated with cetuximab-based first-line therapy. Subgroup analysis of the german non-interventional study ERBITAG

المؤلفون: Karsten G. Stenzel, Mark-Oliver Zahn, O. Rubanov, I. Zander, S.W. Sahm, Friedrich Overkamp, C. Maintz, C. Hering-Schubert, T. Goehler, J. Janssen

المصدر: Annals of Oncology. 30:v218

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::683ca8377a881b061afd9aa03ea89fb3Test
https://doi.org/10.1093/annonc/mdz246.053Test

5

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

المؤلفون: Thomas Bachelot, Alberto Ballestrero, Marco Colleoni, José Valero Alvarez, Amer Sami, Celalettin Camci, Rodrigo Lastra del Prado, Luis De La Cruz Merino, Antonio Bernardo, Peter Barrett-Lee, Yolanda Fernández Pérez, Vladimir Semiglazov, Thierry Petit, Mette Holck Nielsen, C. Langridge, Guillermo López Vivanco, Nik Hauser, Ignacio Porras Quintela, José Manuel Pérez García, Anna-Karin Wennstig, Victoria Dvornichenko, Erik Jakobsen, Guzel Mukhametshina, Heiko Graf, V. Jenkins, Mireille Mousseau, Alfonso Sanchez Muñoz, Pehr Lind, Irina Bulavina, Alexey Manikhas, Bengt Norberg, Xavier Pivot, Per Edlund, Sandeep Sehdev, Valerie Jenkins, Santos Enrech Frances, Nadia Califaretti, V. Müller, G. Curigliano, Duncan Wheatley, Stephen L. Chan, Enrique Espinosa Arranz, S. Osborne, Soeren Linnet, Nana Scotto, J. Gligorov, Volkmar Müller, Tjoung-Won Park-Simon, Karen McAdam, Ann Knoop, Giuseppe Curigliano, X. Pivot, Justine Kilkerr, Georg Heinrich, L. Fallowfield, Francisco Carabantes Ocon, Christopher Wolf, Robert El-Maraghi, Hugues Bourgeois, Christelle Levy, Luca Gianni, Russell Burcombe, Vadim Shirinkin, Huseyin Abali, Etienne Brain, Christoph Tausch, Lidia Perlova-Griff, Claudia Plesse Lefeuvre, Joseph Gligorov, Mikhail Lichinitser, Friedrich Overkamp, S. Verma, Kathryn Monson, Angela Stefania Ribecco, Doris Augustin, Lesley Fallowfield, Saad Tahir, Javier Cassinello Espinosa, Marcus Schmidt, Jacek Jassem, Laurent Zelek, Ruchan Uslu, Richard Simcock, Sherko Kuemmel, Javier Salvador Bofill, A. Knoop, Hervé Bonnefoi, Fikret Arpaci, Silvana Spadafora, Sunil Verma, Hendrik Kroening, Elżbieta Brewczynska

المصدر: Annals of Oncology. 25:1979-1987

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b145cdce1456ae985a553171af8850a2Test
https://doi.org/10.1093/annonc/mdu364Test

6

Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma: Data from the German prospective RCC-Registry

المؤلفون: Martina Jänicke, L. Kruggel, P. J. Goebell, Lothar Müller, Michael Staehler, Friedrich Overkamp, M. Frank, Norbert Marschner

المصدر: Annals of Oncology. 28:v322

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Papillary renal cell carcinomas, business.industry, Hematology, language.human_language, German, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, language, Medicine, Outcome data, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dd7f9129c13295dd81f5ee877937b63bTest
https://doi.org/10.1093/annonc/mdx371.063Test

7

Impact of surgical resection of liver metastases on outcome of patients with KRAS-wildtype exon 2 (KRAS-wt) metastatic colorectal carcinoma (mCRC) treated with a cetuximab-based first-line therapy - Interim analysis of the German non-interventional study ERBITAG

المؤلفون: M. Schwittay, C. Hering-Schubert, Ulf P. Neumann, S.W. Sahm, T. Goehler, M.O. Zahn, Karsten G. Stenzel, Friedrich Overkamp, J. Janssen

المصدر: Annals of Oncology. 27:vi162

مصطلحات موضوعية: Surgical resection, Oncology, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, Hematology, Interim analysis, medicine.disease_cause, medicine.disease, Exon, First line therapy, Internal medicine, Non interventional, medicine, KRAS, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9c61dc08851f134e32d697f882024d92Test
https://doi.org/10.1093/annonc/mdw370.39Test

8

Impact of Tumour Ras/Braf Status on Efficacy of First-Line Panitumumab + Folfiri in Patients (Pts) with Metastatic Colorectal Cancer (Mcrc)

المؤلفون: Meinolf Karthaus, Jan-Henrik Terwey, Friedrich Overkamp, Josef Thaler, R.D. Hofheinz, Richard Greil, H. Kröning, C.-H. Köhne, Laurent Mineur, Eva Fernebro, Kelly S. Oliner

المصدر: Annals of Oncology. 25:iv188

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, Oncology, medicine.medical_specialty, Colorectal cancer, business.industry, Context (language use), Hematology, Odds ratio, medicine.disease, medicine.disease_cause, digestive system diseases, Internal medicine, medicine, FOLFIRI, Panitumumab, KRAS, Progression-free survival, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::07f7a0e94901fd3d40b52272a9a4cdfbTest
https://doi.org/10.1093/annonc/mdu333.51Test

9

7152 POSTER Interim Analysis of a Non-interventional Study of Everolimus After Failure of the First Anti-VEGF Therapy

المؤلفون: Michael Staehler, A. Jakob, R.J. Goebell, Gernot Guderian, Friedrich Overkamp, T. Steiner, Ulrich Kube, C. Doehn, Lothar Bergmann, M. Kindler

المصدر: European Journal of Cancer. 47:S521

مصطلحات موضوعية: Oncology, Anti vegf, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Internal medicine, Non interventional, medicine, Interim analysis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e00c85ff3dc70e23a7b0afadb9c99348Test
https://doi.org/10.1016/s0959-8049Test(11)72067-6

تنقيح النتائج